{"FsPickler":"0.9.6","type":"System.String","value":"@article{Home_2007,\n\tdoi = {10.1007/s00125-007-0653-9},\n\turl = {http://dx.doi.org/10.1007/s00125-007-0653-9},\n\tyear = 2007,\n\tmonth = {mar},\n\tpublisher = {Springer Science $\\mathplus$ Business Media},\n\tvolume = {50},\n\tnumber = {7},\n\tpages = {1561--1562},\n\tauthor = {P. D. Home},\n\ttitle = {Comment on: Nauck $\\lbrace$MA$\\rbrace$, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259{\\textendash}267},\n\tjournal = {Diabetologia}\n}"}